The weight loss trajectory of this medication suggests that moderate sleep apnea may resolve entirely for many users, while severe cases may see substantial enough improvement to reduce CPAP pressure requirements or allow alternative, less cumbersome therapies
Eli Lilly lawsuit
27 Other side effects and risks of GLP-1s include: Dizziness Mild tachycardia (increased heart rate) Headaches Injection site reactions, such as itchiness and redness Hypoglycemia (low blood sugar) Severe Risks & Contraindications While less common, GLP-1s can pose severe risks such as intestinal blockage and gastroparesis 28 , which refer to the delay in gastric emptying without evidence of mechanical obstruction
With facial fat loss, eyelids may droop or look hollow
HSA and FSA funds may be eligible for GLP-1 medications prescribed for a diagnosed condition such as obesity, though plan rules vary
Back Creutzfeldt, W (15 June 2005) 'The [pre-] history of the incretin concept', Regulatory Peptides , 128/2, 87-91